(Q39967565)

16 September 2017

A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer (English)

1 reference

multicenter clinical trial

16 September 2017

0 references

author

David E. Cohn

series ordinal

7

1 reference

16 September 2017

2

Laura J Havrilesky

1 reference

16 September 2017

Angeles Alvarez Secord

series ordinal

1

object named as

Angeles Alvarez Secord

1 reference

16 September 2017

6

Gloria Broadwater

1 reference

16 September 2017

8

Paola A Gehrig

1 reference

16 September 2017

4

Victoria Bae-Jump

1 reference

16 September 2017

5

Nicole D Fleming

1 reference

16 September 2017

David M O'Malley

3

1 reference

16 September 2017

language of work or name

English

0 references

publication date

26 June 2009

1 reference

16 September 2017

1 reference

16 September 2017

114

1 reference

16 September 2017

3

1 reference

16 September 2017

442-447

1 reference

Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy

16 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.005

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.005

Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.005

Surgical stage IV endometrial carcinoma: a study of 47 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.005

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.005

Stage III endometrial cancer: analysis of prognostic factors and failure patterns after adjuvant chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.005

The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.005

Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.005

Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.005

Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.005

Stage IIIC endometrioid corpus cancer includes distinct subgroups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.005

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.005

10.1016/J.YGYNO.2009.06.005

7 January 2021

Identifiers

DOI

1 reference

release_ezw4zhq3z5ehrgb7t6oplrfkw4

16 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ezw4zhq3z5ehrgb7t6oplrfkw4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference